List of Excipients in API niraparib tosylate monohydrate and abiraterone acetate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing niraparib tosylate monohydrate and abiraterone acetate
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Janssen Biotech Inc | AKEEGA | niraparib tosylate monohydrate and abiraterone acetate | 57894-100 | CELLULOSE, MICROCRYSTALLINE | 2038-03-27 |
| Janssen Biotech Inc | AKEEGA | niraparib tosylate monohydrate and abiraterone acetate | 57894-100 | CROSPOVIDONE | 2038-03-27 |
| Janssen Biotech Inc | AKEEGA | niraparib tosylate monohydrate and abiraterone acetate | 57894-100 | FERRIC OXIDE RED | 2038-03-27 |
| Janssen Biotech Inc | AKEEGA | niraparib tosylate monohydrate and abiraterone acetate | 57894-100 | FERRIC OXIDE YELLOW | 2038-03-27 |
| Janssen Biotech Inc | AKEEGA | niraparib tosylate monohydrate and abiraterone acetate | 57894-100 | GLYCERYL MONOCAPRYLOCAPRATE | 2038-03-27 |
| Janssen Biotech Inc | AKEEGA | niraparib tosylate monohydrate and abiraterone acetate | 57894-100 | HYPROMELLOSE | 2038-03-27 |
| Janssen Biotech Inc | AKEEGA | niraparib tosylate monohydrate and abiraterone acetate | 57894-100 | LACTOSE MONOHYDRATE | 2038-03-27 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for niraparib tosylate monohydrate and abiraterone acetate
Excipient focus: CELLULOSE, MICROCRYSTALLINE
niraparib tosylate monohydrate and abiraterone acetate drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Janssen Biotech Inc | niraparib tosylate monohydrate and abiraterone acetate | 57894-100 |
| >Company | >Ingredient | >NDC |
niraparib tosylate monohydrate and abiraterone acetate drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
niraparib tosylate monohydrate and abiraterone acetate drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Janssen Biotech Inc | niraparib tosylate monohydrate and abiraterone acetate | 57894-100 |
| >Company | >Ingredient | >NDC |
niraparib tosylate monohydrate and abiraterone acetate drug variants not containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
niraparib tosylate monohydrate and abiraterone acetate drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Janssen Biotech Inc | niraparib tosylate monohydrate and abiraterone acetate | 57894-100 |
| >Company | >Ingredient | >NDC |
niraparib tosylate monohydrate and abiraterone acetate drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
niraparib tosylate monohydrate and abiraterone acetate drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Janssen Biotech Inc | niraparib tosylate monohydrate and abiraterone acetate | 57894-100 |
| >Company | >Ingredient | >NDC |
niraparib tosylate monohydrate and abiraterone acetate drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERYL MONOCAPRYLOCAPRATE
niraparib tosylate monohydrate and abiraterone acetate drug variants containing GLYCERYL MONOCAPRYLOCAPRATE
| Company | Ingredient | NDC |
|---|---|---|
| Janssen Biotech Inc | niraparib tosylate monohydrate and abiraterone acetate | 57894-100 |
| >Company | >Ingredient | >NDC |
niraparib tosylate monohydrate and abiraterone acetate drug variants not containing GLYCERYL MONOCAPRYLOCAPRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
niraparib tosylate monohydrate and abiraterone acetate drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Janssen Biotech Inc | niraparib tosylate monohydrate and abiraterone acetate | 57894-100 |
| >Company | >Ingredient | >NDC |
niraparib tosylate monohydrate and abiraterone acetate drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
niraparib tosylate monohydrate and abiraterone acetate drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Janssen Biotech Inc | niraparib tosylate monohydrate and abiraterone acetate | 57894-100 |
| >Company | >Ingredient | >NDC |
niraparib tosylate monohydrate and abiraterone acetate drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
niraparib tosylate monohydrate and abiraterone acetate drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Janssen Biotech Inc | niraparib tosylate monohydrate and abiraterone acetate | 57894-100 |
| >Company | >Ingredient | >NDC |
niraparib tosylate monohydrate and abiraterone acetate drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
niraparib tosylate monohydrate and abiraterone acetate drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Janssen Biotech Inc | niraparib tosylate monohydrate and abiraterone acetate | 57894-100 |
| >Company | >Ingredient | >NDC |
niraparib tosylate monohydrate and abiraterone acetate drug variants not containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
niraparib tosylate monohydrate and abiraterone acetate drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Janssen Biotech Inc | niraparib tosylate monohydrate and abiraterone acetate | 57894-100 |
| >Company | >Ingredient | >NDC |
niraparib tosylate monohydrate and abiraterone acetate drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
niraparib tosylate monohydrate and abiraterone acetate drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Janssen Biotech Inc | niraparib tosylate monohydrate and abiraterone acetate | 57894-100 |
| >Company | >Ingredient | >NDC |
niraparib tosylate monohydrate and abiraterone acetate drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
niraparib tosylate monohydrate and abiraterone acetate drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Janssen Biotech Inc | niraparib tosylate monohydrate and abiraterone acetate | 57894-100 |
| >Company | >Ingredient | >NDC |
niraparib tosylate monohydrate and abiraterone acetate drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
niraparib tosylate monohydrate and abiraterone acetate drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Janssen Biotech Inc | niraparib tosylate monohydrate and abiraterone acetate | 57894-100 |
| >Company | >Ingredient | >NDC |
niraparib tosylate monohydrate and abiraterone acetate drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
